Glucose Fluctuations Aggravate Myocardial Fibrosis via the Nuclear Factor-κB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation

Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes

(2021) Meenakshi Sharma et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

(2021) Vincenzo Quagliariello et al.   Cardiovascular Diabetology

Inflammation in Metabolic Cardiomyopathy

(2021) Florian A. Wenzl et al.   Frontiers in Cardiovascular Medicine

NLRP3 Inflammasome and Inflammatory Diseases

(2020) Zheng Wang et al.   Oxidative Medicine and Cellular Longevity

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

(2020) Huan Chen et al.   CARDIOVASCULAR DRUGS AND THERAPY

Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling

(2020) Zhen-Ye Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway

(2020) Shuang Xu et al.   ATHEROSCLEROSIS

Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs

(2019) Rong Hu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways

(2018) Danlu Jiang et al.   CANCER LETTERS

Diabetes, cardiovascular disease and the microcirculation

(2018) W. David Strain et al.   Cardiovascular Diabetology

Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway

(2018) Zhiqiang Sun et al.   CHEMICO-BIOLOGICAL INTERACTIONS

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

(2018) Alena Grebe et al.   CIRCULATION RESEARCH

Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice

(2018) Wu Song et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy

(2017) Beibei Luo et al.   Frontiers in Physiology

Glucose Fluctuations Aggravate Cardiac Susceptibility to Ischemia/Reperfusion Injury by Modulating MicroRNAs Expression

(2016) Shotaro Saito et al.   CIRCULATION JOURNAL

The Inflammasome in Myocardial Injury and Cardiac Remodeling

(2015) Stefano Toldo et al.   ANTIOXIDANTS & REDOX SIGNALING

Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats

(2014) Shotaro Saito et al.   CARDIOVASCULAR RESEARCH

Acute Blood Glucose Fluctuation Induces Myocardial Apoptosis through Oxidative Stress and Nuclear Factor-?B Activation

(2012) Wei Zhang et al.   CARDIOLOGY